Latest filing published 23 Dec 2025 for Integral AD Science Holding CORP., €198.9M.
Insider track record
No signal scores available.
Atlas Venture Fund VIII, L.P.: trading record in brief
Atlas Venture Fund VIII, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Integral AD Science Holding Corp. and Translate Bio, Inc. We count 2 filings; the first trade dates from 2 July 2018 and the latest from 23 December 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 23 December 2025, reports a transaction of €198.9M in Integral AD Science Holding Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Atlas Venture Fund VIII, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,722,770 shares@ US$10.30100.0% of flowCommon stock, $0.001 par valueSEC:0001104659-25-124358:0
- 3,832,010 sharesCommon StockSEC:0000899243-18-019323:0
2 of 2 declarations
